“…HCV-associated end-stage liver disease is one of the main reasons for liver transplantation in the United States and Europe. Liver transplant recipients who also suffer from iron overload are more susceptible to other diseases like serious fungal, bacterial and viral infections (aspergillosis, cryptococcosis, cytomegaly, infections with Staphylococcus aureus, Yersinia species), relapse of hepatocellular carcinoma and nonhepatic cancers, which significantly decrease the post-transplantation survival rate (Kowdley et al, 2005;Alexander et al, 2006;Singh et al, 2008;Dar et al, 2009). Moreover, hemochromatosis phenotypes as a post-transplantation complication were also observed in HFE-wild-type recipients of livers from donors with HFE mutations (Wigg et al, 2003;Ismail et al, 2009).…”